Friday, 6 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Date

Norris Medicines Board Meeting Date

Norris Medicines Limited intimated a prior board meeting on 14 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closed from 01 Oct to 16 Nov 2026.

Source

BSE filing, NSE: NORRIS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Norris Medicines Ltd: key numbers

Share price
₹15.37
Market cap
₹15.37 Cr
Revenue (annual)
₹8.13 Cr
Net profit (annual)
₹-0.28 Cr
P/E (TTM)
-41.9×Sector 42.0×
Promoter holding
34.01%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Norris Medicines Ltd

All →

Other board meeting date announcements

All →